Andriy Derkach

3.8k total citations
100 papers, 1.5k citations indexed

About

Andriy Derkach is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Andriy Derkach has authored 100 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Hematology, 38 papers in Molecular Biology and 21 papers in Genetics. Recurrent topics in Andriy Derkach's work include Acute Myeloid Leukemia Research (24 papers), Multiple Myeloma Research and Treatments (18 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (16 papers). Andriy Derkach is often cited by papers focused on Acute Myeloid Leukemia Research (24 papers), Multiple Myeloma Research and Treatments (18 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (16 papers). Andriy Derkach collaborates with scholars based in United States, Canada and United Kingdom. Andriy Derkach's co-authors include Joshua N. Sampson, Steven C. Moore, Demetrius Albanes, Stephanie J. Weinstein, Lei Sun, Alison M. Mondul, Rachael Z. Stolzenberg‐Solomon, Jerry Lawless, Mary C. Playdon and Fangyi Gu and has published in prestigious journals such as Nature Communications, Nature Genetics and Journal of Clinical Oncology.

In The Last Decade

Andriy Derkach

88 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andriy Derkach United States 22 722 363 328 285 237 100 1.5k
Clara Chen United States 24 604 0.8× 227 0.6× 832 2.5× 182 0.6× 264 1.1× 101 2.6k
Asha Kallianpur United States 25 486 0.7× 191 0.5× 180 0.5× 208 0.7× 151 0.6× 59 1.8k
Robert N. Fontaine United States 26 637 0.9× 295 0.8× 208 0.6× 323 1.1× 177 0.7× 48 2.4k
Yanli Wang China 17 339 0.5× 191 0.5× 186 0.6× 133 0.5× 362 1.5× 45 1.7k
Jamie L. Renbarger United States 20 507 0.7× 238 0.7× 806 2.5× 272 1.0× 89 0.4× 65 1.8k
Albert G. Frauman Australia 28 519 0.7× 410 1.1× 278 0.8× 94 0.3× 211 0.9× 68 2.4k
Ann M. Moyer United States 24 541 0.7× 77 0.2× 311 0.9× 346 1.2× 84 0.4× 109 2.1k
Kara L. Cushing‐Haugen United States 25 496 0.7× 165 0.5× 511 1.6× 381 1.3× 134 0.6× 59 2.5k
Seung Hee Yang South Korea 27 562 0.8× 75 0.2× 245 0.7× 93 0.3× 179 0.8× 126 2.2k
Harry E. Hynes United States 17 435 0.6× 550 1.5× 974 3.0× 210 0.7× 77 0.3× 34 1.9k

Countries citing papers authored by Andriy Derkach

Since Specialization
Citations

This map shows the geographic impact of Andriy Derkach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andriy Derkach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andriy Derkach more than expected).

Fields of papers citing papers by Andriy Derkach

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andriy Derkach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andriy Derkach. The network helps show where Andriy Derkach may publish in the future.

Co-authorship network of co-authors of Andriy Derkach

This figure shows the co-authorship network connecting the top 25 collaborators of Andriy Derkach. A scholar is included among the top collaborators of Andriy Derkach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andriy Derkach. Andriy Derkach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xie, Amy, Kelly R. Pekala, Kanika Arora, et al.. (2025). Meta-analysis reveals differences in somatic alterations by genetic ancestry across common cancers. Nature Genetics. 57(11). 2655–2660.
2.
Watt, Gordon P., Anne S. Reiner, Xiang Shu, et al.. (2025). Polygenic risk of coronary artery disease for long-term survivors of breast cancer. JNCI Journal of the National Cancer Institute. 117(10). 2073–2081. 1 indexed citations
3.
Terry, Alexander R., Andriy Derkach, Kuo‐Kai Chin, et al.. (2025). Patients with AML and an IDH2-R172 mutation exhibit a unique initial response to intensive chemotherapy induction. Blood Advances. 9(13). 3213–3222.
4.
Derkach, Andriy, et al.. (2025). Venous thromboembolism in patients with cancer and factor XI deficiency. Journal of Thrombosis and Haemostasis. 23(10). 3286–3294.
5.
Chin, Kuo‐Kai, Brian Ball, Yasmin Abaza, et al.. (2025). Outcomes of relapsed or refractory acute myeloid leukemia after menin inhibition failure. Blood Advances. 10(5). 1537–1547.
6.
Bewersdorf, Jan Philipp, Claire Harrison, Francesca Palandri, et al.. (2024). Pacritinib Response Is Associated With Overall Survival in Myelofibrosis: PERSIST‐2 Landmark Analysis of Survival. European Journal Of Haematology. 114(2). 238–247. 3 indexed citations
7.
Valtis, Yannis K., Andriy Derkach, Ricardo Ortíz, et al.. (2024). Real-world incidence and prevention of tumor lysis syndrome in chronic lymphocytic leukemia treated with venetoclax. Blood Advances. 8(22). 5806–5813. 1 indexed citations
8.
Chin, Kuo‐Kai, Yannis K. Valtis, Andriy Derkach, et al.. (2024). Intensive chemotherapy after hypomethylating agent and venetoclax in adult acute myeloid leukemia. PubMed. 1(4). 100038–100038. 3 indexed citations
9.
Derkach, Andriy, Billel Gasmi, Theodora Anagnostou, et al.. (2023). T-Cell Exhaustion Signature Predicts Early Relapse after Autologous Stem Cell Transplant for Multiple Myeloma: BMT CTN 0702 Secondary Immune Analysis. Blood. 142(Supplement 1). 3326–3326. 1 indexed citations
10.
Derkach, Andriy, et al.. (2023). Pre-diagnosis dietary patterns and risk of multiple myeloma in the NIH-AARP diet and health study. Leukemia. 38(2). 438–441. 4 indexed citations
11.
Bewersdorf, Jan Philipp, Maximilian Stahl, Justin Taylor, et al.. (2023). E7820, an anti-cancer sulfonamide, degrades RBM39 in patients with splicing factor mutant myeloid malignancies: a phase II clinical trial. Leukemia. 37(12). 2512–2516. 36 indexed citations
12.
Maclachlan, Kylee, Tina Bagratuni, Efstathios Kastritis, et al.. (2022). Waldenström macroglobulinemia whole genome reveals prolonged germinal center activity and late copy number aberrations. Blood Advances. 7(6). 971–981. 1 indexed citations
13.
Epstein‐Peterson, Zachary D., Andriy Derkach, Susan M. Geyer, et al.. (2022). Effect of additional cytogenetic abnormalities on survival in arsenic trioxide-treated acute promyelocytic leukemia. Blood Advances. 6(11). 3433–3439. 7 indexed citations
14.
Rampal, Raajit K., Maria Pinzon-Ortiz, Amritha Varshini Hanasoge Somasundara, et al.. (2021). Therapeutic Efficacy of Combined JAK1/2, Pan-PIM, and CDK4/6 Inhibition in Myeloproliferative Neoplasms. Clinical Cancer Research. 27(12). 3456–3468. 14 indexed citations
16.
Stahl, Maximilian, Kamal Menghrajani, Andriy Derkach, et al.. (2021). Clinical and molecular predictors of response and survival following venetoclax therapy in relapsed/refractory AML. Blood Advances. 5(5). 1552–1564. 108 indexed citations
17.
Liu, Zhiwei, Andriy Derkach, Kelly J. Yu, et al.. (2020). Patterns of Human Leukocyte Antigen Class I and Class II Associations and Cancer. Cancer Research. 81(4). 1148–1152. 16 indexed citations
18.
Jee, Justin, Michael B. Foote, Melissa Lumish, et al.. (2020). Chemotherapy and COVID-19 Outcomes in Patients With Cancer. Journal of Clinical Oncology. 38(30). 3538–3546. 173 indexed citations
19.
Derkach, Andriy, Haoyu Zhang, & Nilanjan Chatterjee. (2017). Power Analysis for Genetic Association Test (PAGEANT) provides insights to challenges for rare variant association studies. Bioinformatics. 34(9). 1506–1513. 12 indexed citations
20.
Derkach, Andriy, Jerry Lawless, & Lei Sun. (2012). Assessment of Pooled Association Tests for Rare Genetic Variants within a Unified Framework. arXiv (Cornell University). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026